-+ 0.00%
-+ 0.00%
-+ 0.00%

IGC Pharma Expands AI-Powered In-Silico Drug Discovery Platform

Benzinga·11/03/2025 13:54:20
Listen to the news

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, today announced an expansion of its AI-powered in-Silico drug discovery platform. The company is now integrating more methodologies, including retrosynthetic analysis, molecular docking, toxicology and genotoxic assessments, and predictive bioactivity modeling, to accelerate the identification and optimization of therapeutic candidates for Alzheimer's disease (AD) and related disorders.